Switzerland has “bet on the right horses” with the messenger RNA (mRNA) vaccines from Moderna and Pfizer/Biontech, which are also effective against new variants, according to Steve Pascolo, an immunologist at Zurich University Hospital.
“If 50% of the population receive two doses of vaccine, Switzerland can expect a summer like in Israel,” he told SonntagsBlick newspaper.
Israel has vaccinated over three-quarters of its adult population in just over three months. Infection rates have plummeted, allowing the country to reopen its economy. Israelis are happily resuming routines that were disrupted over 12 months ago.
Sair Reddy, a researcher at the federal technology institute ETH Zurich, agrees with Pascolo: “This is a realistic prognosis. The mRNA vaccines are clearly more effective against mutations. It will be a very good summer.”
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
The Swiss vaccination campaign is accelerating nationwide (around 51,000 jabs a day), despite hiccups and delays with deliveries. Some 2.6 million Covid-19 doses were administered between late December and April 28, by which time almost 11% of the population had been fully vaccinated.
The Swiss government has ordered nearly 36 million vaccine doses from five companies. Health regulator Swissmedic has given the green light to three Covid-19 vaccines: from Pfizer/BioNTech, Moderna and Johnson & Johnson. But only the first two are being administered.
As part of initial easing, restaurants and bars have resumed outdoor services while theatres, cinemas and concert halls can re-open under strict safety conditions.
On April 21, the government outlined a detailed plan for a phase-out from the Covid restrictions. The gradual lifting of the curbs is linked to the response to an anti-Covid vaccination programme.
Swiss political class divided over reform of EU asylum pact
This content was published on
As a result of the EU's Migration and Asylum Pact, Switzerland must adapt five laws linked to the Schengen/Dublin agreements.
AI can reduce the number of animals needed for research
This content was published on
Swiss researchers have developed a new, AI-supported method that analyses the behaviour of mice in the laboratory more efficiently.
Geneva Conventions conference on Middle East scheduled for March 2025
This content was published on
The conference on the Middle East of the 196 States party to the Geneva Conventions, organised by Switzerland, will take place in Geneva in March.
Lonza to double production of Covid-19 vaccine at Swiss plant
This content was published on
The Swiss firm will add three more production lines to its plant as part of a larger effort to boost Moderna’s global supply of vaccine doses.
Covid-19: Government prepares to greenlight mass events
This content was published on
The Swiss government wants to allow sports and culture events with up to 3,000 spectators from July if the epidemiological situation remains stable.
Plans outlined for gradual phase-out of anti-Covid restrictions
This content was published on
The government has presented a detailed timetable for relaxing Covid restrictions in Switzerland over the next few months.
‘Brave but risky’: Swiss papers react to Covid-19 easing plan
This content was published on
The Swiss media have reacted with surprise, relief and concern following yesterday’s government decision to further relax Covid restrictions.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.